What is the size of the Assisted Reproductive Technology market in 2022?

The Assisted Reproductive Technology market size is USD 31.85 Billion in 2022.

What is the projected CAGR at which the Assisted Reproductive Technology market is expected to grow at?

The Assisted Reproductive Technology market is expected to grow at a CAGR of 19.4% (2023-2032).

List the segments encompassed in this report on the Assisted Reproductive Technology market?

Market.US has segmented the Assisted Reproductive Technology market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product the market has been segmented into Instrument, Accessory & Disposable, and Reagents & Media. By Technology the market has been segmented into In Vitro-Fertilization, Artificial Insemination, Frozen Embryo Transfer, and Other Technologies. By Procedure the market has been segmented into Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor. By End-User the market has been segmented into Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Other End-Users.

List the key industry players of the Assisted Reproductive Technology market?

Cosmos Biomedical Ltd., Microm U.K. Ltd., CooperSurgical, Inc., FUJIFILM Irvine Scientific, Cryolab Ltd., Vitrolife AB, European Sperm Bank, Bloom IVF Centre, Merck KGaA, Ferring B.V., Cook Medical Inc., Fujifilm Holdings Corporation, Genea Biomedx, Thermo Fisher Scientific, Inc., Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., Other Key Players.

Which region is more appealing for vendors employed in the Assisted Reproductive Technology market?

Europe is expected to account for the highest revenue share of 39.2% and boasting an impressive market value of USD 12.5 Billion. Therefore, the Assisted Reproductive Technology industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Assisted Reproductive Technology?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Assisted Reproductive Technology Market.

Assisted Reproductive Technology Market Size

Global Assisted Reproductive Technology Market By Product (Instrument, Accessory & Disposable, and Reagents & Media), By Technology (In Vitro-Fertilization, Artificial Insemination, Frozen Embryo Transfer, and Other Technologies), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor), By End-User (Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, Other End-Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: July 2024
Report ID: 63178
Number of Pages: 297
Format:

- Cosmos Biomedical Ltd.
- Microm U.K. Ltd.
- CooperSurgical, Inc.
- FUJIFILM Irvine Scientific
- Cryolab Ltd.
- Vitrolife AB
- European Sperm Bank
- Bloom IVF Centre
- Merck KGaA Company Profile
- Ferring B.V.
- Cook Medical Inc.
- FUJIFILM Holdings Corporation Company Profile
- Genea Biomedx
- Thermo Fisher Scientific, Inc.
- Millendo Therapeutics, Inc.
- Oxford Gene Technology
- Progyny Inc.
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 63178
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (44)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)